Statistics for Mersana Therapeutics (id:8017 MRSN)

Valuation metrics

Market cap

309.14M

Enterprise value

168.21M

Trailing P/E (ttm)

-1.38

Forward P/E

-3.60

PEG ratio

-3.60

Price/Sales (ttm)

8.87

Price/Book (mrq)

8.24

Enterprise Value/Revenue

4.56

Enterprise Value/EBITDA

-1.07

Overview

Shares outstanding

122.68M

Float

71.29M

Shares short

9.87M

% Held by insiders

0.01%

% Held by institutions

0.93%

Average volume (10 days)

1.85M

Average volume (90 days)

Price summary

52-Week low

1.22

52-Week high

6.28

52-Week change

25.00%

Beta

1.48

50-Day moving average

1.99

200-Day moving average

2.73

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

-214.20%

Operating margin

-95.80%

Operational effectiveness

Return on assets

-75.94%

Return on equity

-465.18%

Income statement

Revenue (ttm)

0.29

Revenue per share (ttm)

0.29

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

-77,797,000.00

Net income to common (ttm)

-74,619,000.00

Diluted EPS (ttm)

-0.85

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

0.00

Total cash per share (mrq)

1.33

Total debt (mrq)

31.50M

Total Debt/Equity (mrq)

390.80

Current ratio (mrq)

235.07%

Book value per share (mrq)

0.31

Cash flow

Cash flow statement

-146,912,000.00

Levered free cash flow (LFCF)

-171,670,000.00